Comparative study of sitagliptin, vildagliptin and alogliptin in patients with type 2 diabetes inadequately controlled with metformin and/or sulfonylurea: a randomized, open labeled trial.
Latest Information Update: 16 May 2016
Price :
$35 *
At a glance
- Drugs Alogliptin (Primary) ; Sitagliptin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Nov 2012 Planned number of patients changed from 200 to 300 as reported by University Hospital Medical Information Network - Japan.
- 12 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 12 Nov 2012 Planned End Date changed from 31 Dec 2014 to 1 Dec 2014 as reported by University Hospital Medical Information Network - Japan.